Clinical Trials Browser

Phase 2/3 × Interventional × eryaspase × Clear all

NCT03674242 2022-08-01

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Phase 2/3 Terminated

Triple Negative Breast Neoplasms